Arcturus Therapeutics Holdings (ARCT) Current Assets (2018 - 2026)

Arcturus Therapeutics Holdings has reported Current Assets for 9 years, with the latest figure at $216.9 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 22.21% year-over-year to $216.9 million; the trailing twelve-month figure through Mar 2026 stood at $216.9 million (down 22.21% YoY), and the FY2025 full-year result was $241.4 million, down 21.09% from the prior year.
• Current Assets for Q1 2026 stood at $216.9 million, down from $241.4 million in the prior quarter.
• The five-year high for Current Assets was $424.6 million in Q1 2023, with the low at $216.9 million in Q1 2026.
• Historically, Current Assets has averaged $322.3 million across 5 years, with a median of $327.0 million in 2022.
• Annual changes were most pronounced in 2022 — Current Assets sank 41.4% — and 2023, when it soared 59.42%.
• Arcturus Therapeutics Holdings' Current Assets stood at $403.3 million in 2022, then dropped by 4.15% to $386.6 million in 2023, then dropped by 20.85% to $306.0 million in 2024, then slipped by 21.09% to $241.4 million in 2025, then fell by 10.17% to $216.9 million in 2026.
• The last three Current Assets figures came in at $216.9 million (Q1 2026), $241.4 million (Q4 2025), and $249.2 million (Q3 2025), per Business Quant data.